Two biologics studied for multiple myeloma

Mar 14, 2007

U.S. medical scientists report investigating two novel biologics for their potential benefit to multiple myeloma patients.

The separate clinical trials are being conducted at the NewYork-Presbyterian Hospital/Weill Cornell Medical Center.

A Phase 2 trial with VEGF Trap will assess the drug's ability to slow tumor growth in patients with multiple myeloma. VEGF Trap is a recombinant human fusion protein that binds VEGF, a key molecule in tumor blood-vessel growth (angiogenesis).

The other investigation is a Phase 1 trial of hLL1, a humanized monoclonal antibody that has shown significant growth inhibition of multiple myeloma and B-lymphoma cells in preclinical studies.

"These two exciting antibody trials may give new hope to myeloma patients with relapsed and refractory disease," said Dr. Ruben Niesvizky, principal investigator of both studies.

Multiple myeloma is a blood cancer that causes white blood cells to become malignant and attack the body's bones, resulting in painful fractures, kidney failure and death. The disease affects an estimated 40,000 Americans annually.

Copyright 2007 by United Press International

Explore further: Study finds inhibitor for COPD lung destruction

Related Stories

GoPro buys virtual reality firm Kolor

43 minutes ago

The company that makes the popular GoPro cameras announced plans Tuesday to buy Kolor, a French-based firm specializing in virtual reality and other video technologies.

Robotically discovering Earth's nearest neighbors

1 hour ago

A team of astronomers using ground-based telescopes in Hawaii, California, and Arizona recently discovered a planetary system orbiting a nearby star that is only 54 light-years away. All three planets orbit ...

Recommended for you

Study finds inhibitor for COPD lung destruction

5 hours ago

In a new study, a research team based at Brown and Yale implicates a specific mitochondrial protein and pathway in the development of chronic obstructive pulmonary disease (COPD) from exposure to cigarette ...

Malarial parasites dodge the kill

13 hours ago

Scientists have uncovered a potential mode of parasite drug resistance in malaria infection, according to a report published in The Journal of Experimental Medicine.

User comments : 0

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.